Title
Date Published
Outcomes with the use of recombinant human erythropoietin in critically ill burn patients.
September 1, 2010
Changes in platelet count in uncomplicated and severe falciparum malaria.
September 1, 2010
Time interval from cigarette smoke exposure to blood donation and markers of inflammation: should a smoking cut-off be designated?
September 1, 2010
Significance of anti-HBc screening of blood donors & its association with occult hepatitis B virus infection: Implications for blood transfusion.
September 1, 2010
Detection of blood-transmissible agents: can screening be miniaturized?
September 1, 2010
Keeping transfusion blood safe.
September 1, 2010
Jehovah’s Witness patients. [Article in Japanese]
September 1, 2010
Blood banks, biobanks, and the ethics of donation.
September 1, 2010
Emergency department blood transfusion predicts early massive transfusion and early blood component requirement.
September 1, 2010
A solution to the problem of studying blood donor-related risk factors when patients have received multiple transfusions.
September 1, 2010
Preoperative evaluation, preparation and outcome prediction. II: preface and comments. [Article in Japanese]
September 1, 2010
Trends in blood collection and transfusion.
September 1, 2010
Blood transfusion practices at a level one trauma centre: a one-year retrospective review.
September 1, 2010
Effects of blood conservation on the incidence of anemia and transfusions in pediatric parapneumonic effusion: a hospitalist perspective.
September 1, 2010
Intravenous Immunoglobulin therapy for anti-E hemolytic disease in the newborn.
September 1, 2010
Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility. [Article in Chinese]
September 1, 2010
Gynecologic surgery and the management of hemorrhage.
September 1, 2010
The morbidly adherent placenta: an overview of management options.
September 1, 2010
Polymerization of human hemoglobin using the crosslinker 1,11-bis(maleimido)triethylene glycol for use as an oxygen carrier.
September 1, 2010
Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.
September 1, 2010